ISSN: 1859 - 2872
Studying the relationship between HbA1c index and body mass index to peripheral neurological complications in elderly patients with type 2 diabetes
Main Article Content
Keywords
Abstract
Objective: To assess the relationship between HbA1c index and body mass index (BMI) to peripheral neurological complications in elderly patients with type 2 diabetes. Subject and method: Tissue study cross-sectional descriptions to assess the relationship between HbA1c index and body mass index (BMI) to peripheral neurological complications in 179 type 2 diabetic patients at Hanoi Medical University Hospital. Result: Small fiber nerve damage of the not good HbA1c control group was 1.9 times higher than that of the control group with good HbA1c with p<0.05. Severe injury peripheral neurological complications in the not good HbA1c control group index were 8.4 times higher than the control group with good HbA1c with p<0.05. Severe injury in the overweight group was 3.2 times higher than the non-overweight group with statistical significance with p<0.05. Conclusion: Not good HbA1c control likely to cause small fiber injury and peripheral neuropathic tendency more severe than the good HbA1c control group. Severe injury peripheral neurological complications at overweight people is higher than the normal BMI group.
Keywords: Peripheral neurological complications, HbA1c index, BMI.
Article Details
References
1. Lương Thanh Điền (2011) Đặc điểm lâm sàng bệnh lý thần kinh ngoại biên trên bệnh nhân ĐTĐ týp 2 tại Bệnh viện Đa khoa Cần Thơ. Tạp chí Y học thực hành (372) - số 3/2007.
2. Nguyễn Thanh Hương (2009) Bước đầu đánh giá tính giá trị và độ tin cậy của bộ công cụ đo lường chất lượng cuộc sống người cao tuổi ở Việt Nam. Tạp chí Y học thực hành (675) - số 9/2009.
3. Nguyễn quốc Anh (2012) Tỷ lệ biến chứng thần kinh ngoại vi ở bệnh nhân ĐTĐ týp 2 điều trị ngoại trú tại Bệnh viện Bạch Mai. Tạp chí Y học Việt nam (213) - số 2 /2011.
4. World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Report of a WHO/IDF consultation:1-4.
5. Thomson FJ, Masson EA, Bouton AJ (1993) The clinical diagnosis of sensory neuropathy in elderly people. Diabet- Med 10(9): 843-846.
6. Boulton AJM, Gries FA, Jervell JA (1998) Guide-lines for the diagnosis and outpatient management diabetic peripheral neuropathy. Diabet Med 15: 508-514.
7. Martin CL, Albers J, herman WH (2006) Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes care 29(2): 34.
8. Solomon Tesfaye (2007) Clinical management diabetic neuropathy. Chapt 14: Clinical fearture of diabetic polyneuropathy. Humana press.
9. Simmons Z, Feldman EL (2002) Update on diabetic neuropathy. Current opinion in neurology 15: 595-603.
10. Ellenberg M (1983) Diabetic neuropathy. Diabetes mellitus: 61-72; 777-800.
11. Zhou L, Li J, Ontaneda D, Sperling J (2011) Metabolic syndrome in small fiber sensory neuropathy. J Clin Neuromuscul Dis 12(4): 235-243.
Article Sidebar
